Back to Top Skip to main content

Call for abstracts open for Military Health System Research Symposium

Military personnel speaking in front of an audience at the Military Health Systems Research Symposium Army Col. Louis Finelli of the Armed Forces Medical Examiner System speaks at a panel discussion during the 2019 Military Health System Research Symposium. (Photo by: MHS)

Recommended Content:

About the MHS | Research and Innovation

Calling all military medical care providers and researchers.

MHSRS is just around the corner!

Abstracts for the 2021 Military Health System Research Symposium are due by March 31.  

MHSRS serves as the Department of Defense’s premier scientific meeting to the unique medical needs of the warfighter. The annual symposium provides a collaborative environment for military medical care providers with deployment experience, DOD scientists, academia, international partners, and industry to exchange information on research advancements.

The theme of this year’s meeting is “Channeling the Challenge – The Agility of Military Medical Research,” and conference programming will focus on four topics: Warfighter Medical Readiness; Expeditionary Medicine; Warfighter Performance; Return to Duty.

In addition, a COVID-19 track will be offered by a series of invited presenters.

Before the MHSRS 2020 meeting was cancelled due to the pandemic, more than 1,800 abstracts spanning more than 50 warfighter-related topic areas had been accepted for oral or poster presentations.

The MHSRS website is the best source of information on the 2021 MHSRS Call for Abstracts, and includes the 2021 breakout sessions and instructions on how to submit an abstract.

The 2021 MHSRS Call for Abstracts will not be extended past the closing date. Anyone planning to submit an abstract(s) should submit the appropriate documents by March 31.

While the location and date of the 2021 MHSRS have not been determined yet, the conference is expected to be held in person if conditions permit. Details will be posted on the MHSRS website when available.

Hundreds of military medical researchers, clinicians, and others from all military services attend MHSRS each year. Attendees have the opportunity to attend a wide range of sessions targeting combat casualty care, military operational medicine including psychological health and resilience, clinical and rehabilitative medicine, medical simulation and robotics, and military infectious diseases.

MHSRS also features an awards presentation honoring individual and team research accomplishments.

You also may be interested in...

DHA-PI 3200.01: Research and Development (R&D) Enterprise Activity (EA)

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): a. Establishes the Defense Health Agency’s (DHA) procedures for the Deputy Assistant Director (DAD), R&D to manage and execute, on behalf of the Assistant Secretary of Defense for Health Affairs (ASD(HA)), the portion of the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation assigned to it (referred to as the “DHP Science and Technology (S&T) Program)”. The DHP S&T Program includes Budget Activities (BAs) 6.1-6.3 and 6.6. The ASD(HA) provides policy, direction, and guidance to inform planning, programming, budgeting, and execution of the DHP RDT&E appropriation in accordance with statute, regulation, and policy in Reference (a). The DAD-R&D, and Component Acquisition Executive (CAE) manage and execute DHP RDT&E Program funds aligned to them on behalf of the ASD(HA). The CAE is responsible for managing BAs 6.4, 6.5, and 6.7 funding, as well as Procurement and Operations and Maintenance funding required to support DHP-funded Acquisition Programs, regardless of acquisition activity. b. Supports the Director, DHA, in developing appropriate DHA management models to maximize efficiencies in the management and execution of DHP RDT&E-funded activities carried out by the Combatant Commands (CCMDs), Services, Uniformed Services University of the Health Sciences (USU), Defense Agencies, and other DoD Components, as applicable. c. Codifies processes to confirm DHP RDT&E funds are applied towards medical priorities and aligned to ASD(HA) policy, direction, and guidance to develop and deliver innovative medical products and solutions that increase the readiness of the DoD medical mission in accordance with Reference (a). d. Supports the following objectives of the R&D EA: (1) Increasing the quantity, quality, and pace of medical research through improved programmatic organization, processes, and oversight. (2) Ensuring DHP RDT&E funded efforts align to ASD(HA) published program guidance that provides resourcing guidance and translates national, departmental, and Service priorities into specific program objectives. (3) Verifying alignment of DHP RDT&E funds to medical priorities and to ASD(HA) policy, direction, and guidance to ensure the development and delivery of medical materiel and knowledge solutions. (4) Facilitating coordination with the CCMDs, Services, USU, Defense Agencies, and other DoD Components, as applicable, to ensure DHP RDT&E funded activities address joint medical capability gaps, and avoid unnecessary duplication.

Guidance on the Establishment of a Human Cell, Tissue, and Cellular and Tissue Based Products Program

Policy

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

Showing results 1 - 2 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.